PRESS RELEASE 


Tenet Receives Subpoenas Regarding Relocation Agreements


SANTA BARBARA, Calif.--(BUSINESS WIRE)--July 15, 2003--Tenet Healthcare
Corporation (NYSE:THC) said the company and several of its subsidiaries
today received administrative subpoenas for documents from the U.S.
Attorney's office in Los Angeles. The subpoenas primarily seek information
about physician relocation agreements since 1995 related to seven Southern
California hospitals owned by Tenet subsidiaries as well as summary
information about physician relocation agreements related to all of its
hospital subsidiaries. The company said it does not know the scope or focus
of the investigation underlying the subpoenas, but said it would cooperate
with the requests.

Separately, the company said it expects a grand jury in San Diego to return
an indictment later this week against its Alvarado Hospital Medical Center
Inc. and, possibly, Alvarado's corporate parent entities. The company
previously disclosed that the hospital could be indicted in an ongoing
investigation related to certain physician relocation agreements at the
311-bed eastern San Diego County facility. On June 6, Alvarado's chief
executive officer, Barry Weinbaum, was indicted in connection with physician
relocation agreements made with a group practice headed by a San Diego
physician who was convicted of Medicare fraud in an unrelated case. Weinbaum
has vehemently denied the charges and said he will vigorously defend himself
in court.

The subpoenas received today from the U.S. Attorney's office in Los Angeles
seek information from Tenet Healthcare Corporation, three corporate
subsidiaries and subsidiaries that own seven of its Southern California
hospitals: Centinela Hospital Medical Center in Inglewood, Daniel Freeman
Memorial Hospital in Inglewood, Daniel Freeman Marina Hospital in Marina del
Rey, John F. Kennedy Memorial Hospital in Indio, Brotman Medical Center in
Culver City, Encino-Tarzana Regional Medical Center in Los Angeles, and
Century City Hospital in Los Angeles.

Physician relocation agreements are a common and accepted practice used by
hospitals across the country to meet a demonstrated need in their
communities for additional or specialized health care resources. Typically,
hospitals pay a portion of a physician's cost to relocate from one community
to another plus income guarantees for a set period of time, usually one
year. In return, physicians typically commit to provide health care services
in the local community for at least three years. The agreements permit the
physicians to refer patients to any hospital, not just the facility that
helped them to relocate. Such agreements are generally permitted under rules
promulgated by the U.S. Department of Health and Human Services.

Tenet said it believes that its current corporate policy on physician
relocation agreements, which has been in place since 1996, is entirely
appropriate under the law. The policy is posted on the company's web site,
www.tenethealth.com. About 42,000 physicians currently have admitting
privileges at Tenet's 114 hospitals in 16 states. Of those, fewer than 2.5%
have relocation agreements now in place, and about 1% is currently eligible
for revenue protection under income guarantees during the start-up of their
practices.

Tenet Healthcare Corporation, through its subsidiaries, owns and operates
114 acute care hospitals with 27,765 beds and numerous related health care
services. Tenet and its subsidiaries employ approximately 116,500 people
serving communities in 16 states. Tenet's name reflects its core business
philosophy: the importance of shared values among partners -- including
employees, physicians, insurers and communities -- in providing a full
spectrum of health care. Tenet can be found on the World Wide Web at
www.tenethealth.com.

Certain statements in this release may constitute forward-looking
statements. They are based on management's current expectations and could be
affected by numerous factors and are subject to various risks and
uncertainties. Certain of those risks and uncertainties are discussed in the
Company's filings with the Securities and Exchange Commission, including the
Company's transition report on Form 10-K for the 7-month period ended Dec.
31, 2002 and quarterly reports on Form 10-Q. Do not rely on any
forward-looking statement, as we cannot predict or control many of the
factors that ultimately may affect our ability to achieve the results
estimated. We make no promise to update any forward-looking statement,
whether as a result of changes in underlying factors, new information,
future events or otherwise.